Skip to main content
National Advisory Committee on Blood and Blood Products (NAC)
Main navigation
Blood Shortage
Endorsements
Guidelines & Recommendations
Blood Component Transfusion Recommendations
Plasma Protein and Related Products Recommendations
Special Testing / Modification Recommendations
Adverse Event Recommendations
Infection Prevention and Control
Archived Documents
Links & Resources
Citations
EN
FR
Open Menu
Breadcrumb
Home
Current:
Guidelines & Recommendations
Guidelines & Recommendations
Blood Component Transfusion Recommendations
NAC Patient Blood Management Statement
NAC Position Paper: Utilization and Inventory Management of Group O RH(D)- Negative Red Cells
NAC Recommendations for Management of Dual Inventory of Solvent-Detergent Plasma and Standard Frozen Plasma
NAC Recommendations for the Use of Solvent-Detergent Plasma in Canada
NAC Statement on Perioperative Autologous and Matched Donations
Whole Blood, Leukocytes Reduced Recommendations
Plasma Protein and Related Products Recommendations
Immunoglobulin Utilization Statement
NAC Statement on Clinical Equivalency of Select Fractionated Plasma Protein Products
NAC Statement on Factor XIII Concentrate Use
NAC Statement on Fibrinogen Concentrate Use in Acquired Hypofibrinogenemia
NAC Statement on Recombinant Factor VIIa
Recommendations for Use of Prothrombin Complex Concentrates in Canada
Special Testing / Modification Recommendations
Cytomegalovirus (CMV)
NAC Statement on RBC Genotyping
Recommendations for Use of Irradiated Blood Components in Canada
RHD Genotyping in Prenatal Patients
Supplement to the NAC-CCNMT Recommendations for Use of Irradiated Blood Components in Canada
Adverse Event Recommendations
Canadian Transfusion Adverse Event Reporting Form
NAC Letter to CBS-PTBLC - Urgent Need to Transform the Canadian Hemovigilance System: A Call to Action
Overview of Adverse Transfusion Reaction Reporting for Hospitals in Canada - Supplement: Contacts for National ATR Report Recipients and Provincial TTISS Personnel
Overview of Adverse Transfusion Reaction Reporting for Hospitals in Canada: a NAC and Québec Hemovigilance System Collaborative Initiative
Recommendations for the Notification of Recipients of a Blood Component Recall
Infection Prevention and Control
Infection Prevention and Control Considerations for Return of Blood Components and Products to Inventory
